Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer

ClinicalTrials.gov ID: NCT00014118

Public ClinicalTrials.gov record NCT00014118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial OF Chemoradiation For Organ Preservation In Resectable Stage III or IV Squamous Cell Carcinomas Of The Larynx Or Oropharynx

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by radiation therapy and chemotherapy in treating patients who have stage III or stage IV cancer of the larynx or stage III or stage IV cancer of the oropharynx.

Study identification

NCT ID
NCT00014118
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
Not listed

Conditions and interventions

Interventions

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 6, 2001 (Actual)
Primary completion
Mar 2007 (Actual)
Completion
May 2009 (Actual)
Last update posted
Jun 15, 2023

2001 – 2009

United States locations

U.S. sites
47
U.S. states
10
U.S. cities
31
Facility City State ZIP Site status
Baptist Cancer Institute - Jacksonville Jacksonville Florida 32207 —
Watson Clinic, LLC Lakeland Florida 33804-5000 —
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611-3013 —
Hematology and Oncology Associates Chicago Illinois 60611 —
Mercy Hospital and Medical Center Chicago Illinois 60616 —
Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey Illinois 60426 —
Midwest Center for Hematology/Oncology Joliet Illinois 60432 —
Cancer Care and Hematology Specialists of Chicagoland - Niles Niles Illinois 60714 —
Hematology Oncology Associates - Skokie Skokie Illinois 60076 —
Hematology/Oncology of the North Shore at Gross Point Medical Center Skokie Illinois 60076 —
Siouxland Hematology-Oncology Associates, LLP Sioux City Iowa 51101 —
Mercy Medical Center - Sioux City Sioux City Iowa 51104 —
St. Luke's Regional Medical Center Sioux City Iowa 51104 —
Cancer Center of Kansas, PA - Chanute Chanute Kansas 66720 —
Cancer Center of Kansas, PA - Dodge City Dodge City Kansas 67801 —
Cancer Center of Kansas, PA - El Dorado El Dorado Kansas 67042 —
Cancer Center of Kansas, PA - Kingman Kingman Kansas 67068 —
Southwest Medical Center Liberal Kansas 67901 —
Cancer Center of Kansas, PA - Newton Newton Kansas 67114 —
Cancer Center of Kansas, PA - Parsons Parsons Kansas 67357 —
Cancer Center of Kansas, PA - Pratt Pratt Kansas 67124 —
Cancer Center of Kansas, PA - Salina Salina Kansas 67042 —
Cancer Center of Kansas, PA - Wellington Wellington Kansas 67152 —
Associates in Womens Health, PA - North Review Wichita Kansas 67203 —
Cancer Center of Kansas, PA - Medical Arts Tower Wichita Kansas 67208 —
Cancer Center of Kansas, PA - Wichita Wichita Kansas 67214 —
CCOP - Wichita Wichita Kansas 67214 —
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas 67214 —
Wesley Medical Center Wichita Kansas 67214 —
Cancer Center of Kansas, PA - Winfield Winfield Kansas 67156 —
Borgess Medical Center Kalamazoo Michigan 49001 —
West Michigan Cancer Center Kalamazoo Michigan 49007-3731 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
Aultman Cancer Center at Aultman Hospital Canton Ohio 44710-1799 —
MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland Ohio 44109 —
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104-4283 —
Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania 19111-2497 —
Guthrie Cancer Center at Guthrie Clinic Sayre Sayre Pennsylvania 18840 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 —
Mary Babb Randolph Cancer Center at West Virginia University Hospitals Morgantown West Virginia 26506 —
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin 54301-3526 —
Green Bay Oncology, Limited at St. Mary's Hospital Green Bay Wisconsin 54303 —
St. Mary's Hospital Medical Center - Green Bay Green Bay Wisconsin 54303 —
St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin 54307-3508 —
Bay Area Cancer Care Center at Bay Area Medical Center Marinette Wisconsin 54143 —
Marshfield Clinic - Marshfield Center Marshfield Wisconsin 54449 —
Marshfield Clinic - Indianhead Center Rice Lake Wisconsin 54868 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00014118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2023 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00014118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →